University of Copenhagen, Panum Institute, Health faculty,
Welcome,         Profile    Billing    Logout  
 7 Trials 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lundgren, Jens
NCT05780268: LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed
3
314
Europe, US, RoW
LY3819253, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Eli Lilly and Company, University of Minnesota
COVID-19
02/21
02/21
NCT05780424: BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed
3
353
Europe, US, RoW
BRII-196, BRII-198, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Brii Biosciences Limited, University of Minnesota
COVID-19
06/21
10/22
NCT05780281: VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed
3
367
Europe, US, RoW
VIR-7831, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Vir Biotechnology, Inc., GlaxoSmithKline, University of Minnesota
COVID-19
06/21
10/22
NCT05780437: AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed
3
1455
Europe, US, RoW
AZD7442, AZD8895 + AZD1061, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, AstraZeneca, University of Minnesota
COVID-19
01/22
06/23
NCT05780463: MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed
3
485
Europe, US, RoW
MP0420, ensovibep, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Molecular Partners AG, University of Minnesota
COVID-19
02/22
06/23
TICO, NCT04501978 / 2020-003278-37: ACTIV-3: Therapeutics for Inpatients With COVID-19

Completed
3
2753
Europe, US, RoW
LY3819253, Placebo, Remdesivir, VIR-7831, BRII-196/BRII-198, AZD7442, AZD8895 + AZD1061, MP0420, ensovibep, PF-07304814
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Eli Lilly and Company, Vir Biotechnology, Inc., GlaxoSmithKline, Brii Biosciences Limited, AstraZeneca, Molecular Partners AG, Pfizer, University of Minnesota
Covid19
04/22
07/23
NCT05780541: PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Terminated
3
58
Europe, US
PF-07304814, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Pfizer, University of Minnesota
COVID-19
04/22
07/23
Raben, Dorthe
No trials found

Download Options